Thursday, October 11, 2018

IO Therapy in mCRC: Ipilimumab + Nivolumab https://t.co/R9jcdQY4dH


from Twitter https://twitter.com/PeerMarisa

October 11, 2018 at 11:14AM
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)